Lawyers and Settlements
March 19, 2010

GlaxoSmithKline (GSK), the pharmaceutical giant responsible for medications like Advair, Geritol and Zantac, has seen an increased number of lawsuits related to SSRI birth defects stemming from its popular antidepressant, Paxil.

Paxil, a selective serotonin reuptake inhibitor (SSRI), has resulted in three separate kinds of lawsuits since its introduction to the market in 1992: cases citing the medication’s addictive nature, those citing the suicidal tendencies it can provoke and those that cite the frequency of birth defects in expectant mothers taking the medication.

SSRI medications have been linked to serious lung and heart defects in newborns, including persistent pulmonary hypertension, a disorder of the respiratory system that severely restricts the arteries causing the blood pressure in the pulmonary artery of the heart to rise to dangerous levels.

Read entire article:  http://www.lawyersandsettlements.com/articles/13802/ssri-birth-defects-side-effects-pphn-2.html

« Return to news items

News Feed

Related Posts

• The Daily Mail: UK Drug Regulatory Agency warns pregnant women of antidepressants danger to their unborn child (4)
• Update of Swedish Study Upholds Concern for Antidepressant Induced Birth Defects (0)
• Paxil Birth Defects Lawyers Site Offers News And Information About Antidepressant Heart Defects (0)
• New Study: Antidepressants Linked to Birth Defects (0)
• Lawyers & Settlements—Mom Alert: Would you want a 68% Higher Risk of Miscarriage? (Antidepressants & Pregnancy study) (0)

Tags: antidepressants, birth defects, Heart defects, lung defects, Paxil, PPHN, pregnant women, pulmonary hypertension, SSRIs

This entry was posted on Friday, March 19th, 2010 at 10:15 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.